Robertet acquires Phasex to expand its extraction capabilities
The supplier of natural ingredients for flavors and fragrances has signed an agreement to acquire Phasex, a pioneer in supercritical CO2 extraction, headquartered in North Andover, Massachusetts, USA.
Founded in 1981, Phasex focuses on three market segments: natural products, biopharmaceuticals and polymers.
Supercritical CO2 extraction technology enables the extraction of aromatic or functional ingredients from solid biomass or liquid feedstocks using supercritical carbon dioxide. Supercritical CO2 is more environmentally friendly than existing alternatives such as hexane, butane and ethanol. The supercritical process requires the use of pressure and temperature to reach the supercritical phase, where CO2 is between liquid and gas. In this phase, CO2 has a unique solubility ability and can therefore remove certain components from the matrix material.
Phasex has been at the forefront of this technology since its inception, from R&D and pilot to large-scale production. The company has 30 employees and has annual sales of between €5 million and €12 million ($5.44 million to $13.06 million) over the past five years. Robertet said he wants to double the company's revenues in the coming years, particularly by developing a new range of natural ingredients for flavors and fragrances.
The acquisition of a supplier that Robertet has been working closely with since 2018 will help the company strengthen its production capabilities and expand CO2 extraction capabilities to North American customers.
"The acquisition of Phasex is an important step forward for us. Robertet is now the first company in the flavors and fragrances industry to invest in CO2 extraction in North America, with a focus on high added value extracts for the flavor and nutricosmetics industries. By integrating Phasex's expertise, we will further consolidate our leading position in natural ingredients while developing more sustainable and efficient solutions for our customers. With this transaction, we strengthen our industrial base in North America, which is one of the key drivers to achieve our goal of reaching €1 billion in total sales by 2030," said Jérôme Bruhat, CEO of the Robertet Group.
2026-10-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
DSM-Firmenich sells majority of ROBERTET shares
-
Robertet partners with Aethera to strengthen its active ingredients offering
-
Arkema's New Singapore Plant Commences Operations, Tripling Polyamide Capacity
-
China’s TiO₂ Industry Launches Sixth Price Hike Wave as More Than 20 Producers Follow
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
Cracking Europe: When the Chemical Empire Loses Its Heat
-
A New Obesity Pill Enters the Arena With Double-Digit Weight Loss
-
Wegovy Slips on Price While Mounjaro Defends Its Weight-Loss Crown
-
Vertex Pushes Gene Therapy Into Younger Children With Blood Disorders
-
Lilly’s Mounjaro Enters China’s State Insurance System
Recommend Reading
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
Arkema and ENNEX Forge Global Alliance to Power the Next Generation of Safer, Smarter Battery Separators
-
EU Finalizes Anti-Dumping Duties on Chinese Adipic Acid as Chemical Trade Enters a Rule-Intensive Phase
-
Strait of Hormuz Reopens, Oil Prices Plunge: Is the Chemical Price Rally Over?
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
Business Society September 23, 2026 DOP Trend Analysis: Clear Decline
-
Business Society’s Market Outlook for Dichloromethane on September 4, 2026: Volatile Fluctuations
-
Business Society’s Trend Analysis for Hydrofluoric Acid on September 18, 2026: Volatile Consolidation
-
This Week's Activated Carbon Prices Rose (2.2-2.6) in China
-
Acrylic Acid Market "Hovers" Between Rise and Fall, When is This Temporary Calm Expected to End in China?